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Background: Though traditional Korean medicine plays an important role in the Korean parallel health care system,
there is limited information about the preference and usage of traditional Korean medicine compared to Western
medicine because they have different disease classification systems. The aim of this study is to determine the relative
preference for traditional Korean medicine using data acquired nationwide.
Methods: Data from the 2008 Korea Health Panel were analyzed to determine the preference of medical services by
disease. The use of traditional Korean medicine use is defined by the type of medical institution they used. Disease
types, number of visits and out of pocket expenditures were analyzed.
Results: Traditional Korean medicine was used in only a small number of cases that were emergencies or hospitalization.
However, in terms of outpatient services, traditional Korean medicine was used in 7.8% of all cases and represented 9.9%
of total medical costs. Among disease groups, traditional Korean medicine use was higher in patients with nervous
system and musculoskeletal system diseases. And patients with musculoskeletal and nervous system diseases such as
arthrosis were the most likely to use traditional Korean medicine particularly in an outpatient setting.
Conclusions: Korean characteristics of service use resemble the complementary and alternative medicine use in other
countries in terms of disease group, and the complementary and alternative medicine should be considered to estimate
the burden of disease in countries with parallel health care systems, such as Korea. This is the first study determined the
actual preference of traditional Korean medicine for specific chronic diseases.
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The use of complementary and alternative medicine
(CAM) is a worldwide phenomenon [1]. In some Asian
and African countries, 80% of the population use CAM
for primary health care. Even in many developed coun-
tries, 70–80% of the population use at least some form
of CAM [1]. For example, in the United States, approxi-
mately 38% of adults and 12% of children used some
form of CAM in 2007 [2]. In Europe, approximately 35%
of cancer patients reported the use of some form of
CAM, though prevalence of use varies by country [3].
CAM could be defined as “a group of diverse medical
and health interventions, practices, or disciplines that are
not generally considered part of conventional medicine”
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unless otherwise stated.and body practices. Also traditional medicine such as
Ayurvedic medicine, traditional Chinese medicine was
included in CAM [1]. Korea has its own traditional
medicine like Japan, Malaysia and Vietnam [5]. Though
traditional Korean medicine (TKM) has some similar-
ities to traditional Chinese medicine, Koreans have de-
veloped their own methodology for treating diseases,
such as Sasang constitutional medicine [6]. TKM is
primarily composed of acupuncture, moxibustion and
herbal medicine [6]. Korea has a parallel health care
system consisting of TKM and Western medicine [7,8].
The general system of TKM resembles Western medi-
cine. They each have their own six-year undergraduate
education and subsequent licensing examination. There
are TKM hospitals and clinics in much the same way there
are Western hospitals and clinics. In 2008, the numbers of
Western medicine doctors and TKM doctors were 95,013
and 17,473 respectively. Also the number of Westerns is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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hospital was 2,195. On the contrary, the number of TKM
hospital was only 148 [9,10]. Services such as acupunc-
ture that are provided by TKM doctors (generally
referred to as doctors of Korean medicine (DKM)) are
partially covered by the National Health Insurance of
Korea. In a national survey of Korean citizens, the preva-
lence of CAM use was approximately 29% in 1999. Of
those CAM users, approximately half (15%) received
medical attention from an DKM [11]. A more recent
survey of the Korean population conducted in 2006
indicated that the prevalence of CAM use was 74.8% and
the prevalence of TKM use was at 31.6% [12]. The med-
ical cost of TKM, defined as the cost of TKM hospitals
and clinics, is approximately one billion dollars, which
represents 3.9% of total medical costs covered by
national health insurance according to the 2008 national
health insurance statistics [10].
Though TKM plays a substantial role in the Korean
health care system and the cost of TKM is not negligible,
it is difficult to determine the proportion of Korean citi-
zens using TKM to treat a specific disease or condition.
Though it is possible to estimate TKM usage in terms of
total medical cost, the preference of each patient for TKM
versus Western medicine for a given disease is not well
understood. Although it is known that the use of TKM is
higher for the treatment of musculoskeletal, endocrine,
obstetric and gynecological conditions, the prevalence of
using TKM to treat specific diseases has not yet been
reported [11]. This is largely because there are different
disease classification systems for TKM and Western medi-
cine. In Western medicine, diseases are generally classified
by international classification of diseases (ICD) codes [13].
In Korea, the Korean version of ICD-10 (KCD) is currently
applied when diagnosing diseases using Western medi-
cine, while the diagnosis of diseases using TKM typically
involves the TKM diagnosis system. Since TKM has a
distinctive, diagnostic approach, Pattern Identification
(PI), Disease classification system of TKM is composed
to reflect the PI. It categorized the body condition
according to the quantity of Qi or Blood such as
deficiency of Qi or blood or Sasang constitution such
as So-eumin, So-yangin, Tae-umin and Tae-yang-in).
Therefore, though the total number of services or
total cost of TKM is available, disease-specific data is
generally not.
A standard matching algorithm between ICD-codes and
the TKM diagnosis system was developed to account for
the differences between Western and TKM disease classi-
fications [14]. However, according to this algorithm, one
TKM diagnosis code corresponds to multiple ICD codes,
making practical use of the algorithm almost impossible
[15]. For example, the TKM diagnosis of back pain could
be matched to the ICD code for kyphosis and lordosis(M40), other intervertebral disc disorders (M51), coxar-
throsis (M16), or a sprain or strain of the lumbar spine
(S33.5). The TKM diagnosis system was reconstructed in
2009 to address some of these shortcomings [16]. In the
new diagnosis system, a diagnosis should be made based
on the KCD in principle even when TKM is used. But spe-
cific conditions that cannot be classified using original
KCD are classified as U20-98 of KCD. Thus, the TKM
diagnosis system is now integrated with ICD codes, and
this new classification system is called KCD-6. However,
because there is still a special diagnosis code for TKM,
patients with the same symptoms may still be classified
under different diagnosis codes depending on the insti-
tution. Therefore, it is still difficult to determine patient
preferences for using TKM or Western medicine to
treat a specific disease. In Korea Health Panel, each dis-
ease was defined by patients during a survey conducted
by trained reviewers as part of the Panel. Disease classi-
fication was based on a grouping system that includes
298 diseases. This system is used for statistical pur-
poses for national health insurance claims and is
matched with KCD codes [17]. This made it possible
for the Korea Health Panel to determine a patient’s
preference for medical services by disease. In this study,
the preference and relative cost of TKM by specific disease
was assessed using data collected by the Korea Health
Panel in order to better understand the preference of
TKM in the parallel health care system in Korea.
Methods
In this study, results from the integrated version of the
2008 Korea Health Panel (β-version 1.1.1) were analyzed
to determine medical service use by disease [18]. Korea
Health Panel is a nationwide survey to catch the health
service use behavior of Korean. In integrated version of
the 2008 Korea Health Panel, the surveyed were com-
posed of 21,787 of 7,006 families that were selected by
two-stage cluster sampling from the Korean census in
2005. Their health service use behaviors such as in-
patient and outpatient service use were examined by
trained interviewer. A detailed description of the Korea
Health Panel was presented elsewhere [18,19]. Due to
the parallel system of Korea, TKM is only provided in
TKM medical institutions. Some institutions such as
health care centers were the exceptions and mixed
provision is allowed. Therefore, the use of Western
medicine and TKM was classified based on the medical
institution where a patient sought treatment. Patients
were asked “What medical institution did you use to
treat this specific case?” and a trained interviewer re-
corded the kind of the institution. The use of a tertiary
hospital, general hospital, or hospital and clinic was
classified as Western medicine use and the use of TKM
hospitals and clinics was classified as TKM use. The use
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service use, and the use of other medical institutions not
located in Korea, health care centers and sub-centers,
health center county hospitals, and long term care hos-
pitals was classified as other service use due to their
mixed provision of both Western medicine and TKM.
TKM was frequently used for outpatient services and
a disease-specific preference was defined. Patient diagno-
ses were acquired from survey data, and diagnoses were
then classified by the disease classification code of the
Korea Health Panel. When patients used a clinic for
multiple reasons, the primary diagnosis code was used
for classification. The top 20 diseases for which TKM
was used were then determined. The disease group spe-
cific preference was also analyzed using a 20-disease
group system used by the Korea Health Panel [18]. The
cost and cases of selected diseases and disease groups
were investigated.
The frequency of TKM use by patients with chronic
diseases was investigated using data from the Korea
Health Panel also. Patients were asked whether they had
a chronic disease and if the diseases had been diagnosed
by a physician in the panel. Among the determined top
20 diseases for TKM use, acute diseases and injuries by
diseases characteristics are excluded. Data describing
chronic diseases and outpatient services were matched
to patient identifier. The medical uses of patients due to
their specific chronic disease were only included in the
analysis. As a result, the top ten chronic diseases in-
cluded arthrosis (M15–M19), soft tissue disorders
(M60–M79), other diseases of the skin and subcutane-
ous tissues (L00–L08), gastritis and duodenitis (K29)
and other dorsopathies (M40–M49, M53–54). The num-
bers of outpatients visits due to their chronic disease of
each patient were identified and annual average number
and cost of outpatients service use were estimated. Cost
was measured by the Korea Health Panel survey which
determined costs paid directly by patients, including
copayment and the cost of care not covered by national
health insurance. Costs paid by the insurer were ex-
cluded in the survey. And the cost of herbal medicines
at TKM hospitals and clinics was included, but the cost
of prescribed medications from a pharmacy was ex-
cluded, as was the cost of national health insurance. For
top 10 frequent TKM use diseases, the average number
and cost of outpatient services was provided by Western
medicine, dental and other medical service, TKM re-
spectively. This study used public data from the Korea
Health Panel that did not include any personal identifi-
cation, and the survey conformed to local legislation
and the Declaration of Helsinki. The cost, originally
measured in Korean won, was converted to US dollars
(1 $=1108.9 won) [20]. SAS 9.2 (SAS institute, Inc., Cary,
NC) was used for data analysis.Results
Of the 2,704 hospitalized cases in 2008, 2,624 (97.0 ±
0.33%) cases were Western medicine use cases. Sixty
(2.2 ± 0.28%) were dental and other services use cases,
and 20 were (0.7 ± 0.16%) TKM use cases. TKM repre-
sented 1.0% of total in-patient medical costs. TKM use
for emergency services was similar; only 0.4 ± 0.14% of
those surveyed used TKM, representing 0.1% of total
emergency medical costs for 2008.
Of the 238,202 cases that used outpatient services in
2008, 204,110 cases were Western medical services use
cases, 15,594 were dental services and other services use
cases, and 18,498 (7.8 ± 0.05%) were TKM use cases
(Table 1). According to the Korea Health Panel survey,
0.4 million US dollars were spent on TKM in 2008,
which represents 9.9% of the total costs for outpatient
services. Thus, for outpatient services, the proportion of
TKM service costs is higher than the proportion of
TKM use cases. The cost of Western medical services
was 2.1 million US dollars, representing 55.4% of the
cost of total outpatient services. The cost of dental and
other medical services was 34.7% of the cost of total out-
patient services (Table 1).
Table 1 illustrates the cost of medical care by disease
group also. The cases of TKM use were varied by disease
group. The proportion of TKM use was highest in dis-
eases of the nervous system (G00–G99), with 25.1 ±
0.75% of the total cases with nervous system diseases
using outpatient services. The prevalence of TKM use
was also high in diseases of the musculoskeletal system
and connective tissue (M00–M99) (22.4 ± 0.19%); symp-
toms, signs and abnormal clinical and laboratory find-
ings not elsewhere classified (R00–R99) (13.9 ± 0.64%),
and injury, poisoning and certain other consequences of
external causes (S00–T98) (13.8 ± 0.30%). These four
disease groups represented three quarters of all TKM
outpatient service use. However, none of the cases with
certain conditions originating in the perinatal period
(P00–P96) and with congenital malformations, deforma-
tions and chromosomal abnormalities (Q00–Q99) was
determined as TKM use. The cost of TKM outpatient use
followed a similar pattern. It varied from 0% for cases with
certain conditions originating in the perinatal period
(P00–P96) and with congenital malformations, deforma-
tions and chromosomal abnormalities (Q00–Q99), to
34.8% for cases in the case of symptoms, signs and ab-
normal clinical and laboratory findings not elsewhere clas-
sified. Generally, the proportion of TKM outpatient
service costs was higher than the proportion of TKM use
cases, The following disease groups, the cost of TKM ex-
ceeds 20% of total cost in each disease group: diseases of
the blood and blood-forming organs and certain disorders
involving immune mechanisms (D50–D89); diseases of
the nervous system; diseases of the musculoskeletal
Table 1 Number of outpatient cases and cost of outpatient medical services by disease groupa)

















Certain infectious and parasitic
diseases (A00-B99)
3,094 99.0% 31.6 97.8% 24 0.7% 0.7 2.2% 7 0.2% 0.0 0.1% 3,124 32.3
(0.17) (0.15) (0.08)
Neoplasms (C00–D48) 3,108 98.6% 163.6 98.3% 30 1.0% 2.6 1.6% 13 0.4% 0.1 0.1% 3,151 166.4
(0.21) (0.17) (0.11)
Diseases of the blood and blood-
forming organs and certain disorders
involving the immune system
(D50–D89)
353 97.5% 3.5 71.7% 9 2.5% 1.4 28.3% 0 0.0% 0.0 0.0% 362 4.9
(0.82) (0.82) (0.00)
Endocrine, nutritional and metabolic
diseases (E00–E90)
8,204 98.6% 78.9 93.4% 91 1.1% 5.4 6.4% 25 0.3% 0.2 0.2% 8,320 84.5
(0.13) (0.11) (0.06)
Mental and behavioral disorders
(F00–F99)
3,080 94.2% 48.6 89.6% 163 5.0% 5.2 9.6% 26 0.8% 0.5 0.8% 3,269 54.2
(0.41) (0.38) (0.16)
Diseases of the nervous system
(G00–G99)
2,465 74.5% 42.3 72.6% 830 25.1% 15.9 27.3% 15 0.5% 0.1 0.1% 3,310 58.2
(0.76) (0.75) (0.12)
Diseases of the eye and adnexa
(H00–H59)
7,625 99.1% 93.5 98.7% 64 0.8% 1.2 1.3% 5 0.1% 0.0 0.1% 7,694 94.8
(0.11) (0.10) (0.03)
Diseases of the ear and mastoid
process (H60–H95)
2,790 98.1% 19.6 93.4% 52 1.8% 1.4 6.6% 1 0.1% 0.0 0.1% 2,843 21.0
(0.25) (0.25) (0.04)
Diseases of the circulatory system
(I00–I99)
25,543 93.2% 159.4 88.6% 1,696 6.2% 19.5 10.9% 174 0.6% 0.9 0.5% 27,413 179.8
(0.15) (0.15) (0.05)
Diseases of the respiratory system
(J00–J99)
58,716 98.7% 207.9 89.4% 736 1.2% 21.8 9.4% 63 0.1% 2.8 1.2% 59,515 232.5
(0.05) (0.05) (0.01)
Diseases of the digestive system
(K00–K93)
10,301 43.3% 175.2 12.2% 437 1.8% 13.1 0.9% 13,080 54.9% 1,243.0 86.8% 23,818 1,431.3
(0.32) (0.09) (0.32)
Diseases of the skin and subcutaneous
tissues (L00–L99)
7,670 96.1% 72.4 81.6% 305 3.8% 14.9 16.8% 7 0.1% 1.4 1.6% 7,982 88.7
(0.22) (0.21) (0.03)
Diseases of the musculoskeletal system
and connective tissues (M00–M99)
37,460 77.1% 279.6 69.9% 10,909 22.4% 119.6 29.9% 237 0.5% 0.9 0.2% 48,606 400.2
(0.19) (0.19) (0.03)
Diseases of the genitourinary system
(N00–N99)




















Table 1 Number of outpatient cases and cost of outpatient medical services by disease groupa) (Continued)
Pregnancy, childbirth and the
puerperium (O00–O99)
199 94.8% 8.0 96.0% 11 5.2% 0.3 4.0% 0 0.0% 0.0 0.0% 210 8.3
(1.54) (1.54) (0.00)
Certain conditions originating in
the perinatal period (P00–P96)





77 100.0% 3.0 100.0% 0 0.0% 0.0 0.0% 0 0.0% 0.0 0.0% 77 3.0
(0.00) (0.00) (0.00)
Symptoms, signs and abnormal
clinical and laboratory findings,
not elsewhere classified (R00–R99)
2,518 86.0% 45.4 65.2% 407 13.9% 24.2 34.8% 3 0.1% 0.0 0.1% 2,928 69.6
(0.64) (0.64) (0.06)
Injury, poisoning and certain
other consequences of external
causes (S00–T98)
11,159 84.5% 100.5 77.1% 1,821 13.8% 14.3 10.9% 225 1.7% 15.6 12.0% 13,205 130.4
(0.31) (0.30) (0.11)
External causes of morbidity and
mortality and other
12,549 86.5% 482.4 72.7% 723 5.0% 110.0 16.6% 1,228 8.5% 71.4 10.8% 14,500 663.8
(0.28) (0.18) (0.23)
Total 204,110 85.7% 2,139.3 55.4% 18,498 7.8% 382.7 9.9% 15,594 6.5% 1,341.4 34.7% 238,202 3,863.4
(0.07) (0.05) (0.05)
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abnormal clinical and laboratory findings not elsewhere
classified. Among these groups, treating diseases of the
musculoskeletal system and connective tissue cost the
most at 0.1 million US dollars (Table 1).
Table 2 displays the cases and proportion of cases, and
the cost and proportion of cost by medical service cat-
egory for the top 20 diseases. The top 20 diseases were
listed by cases of outpatient visits for TKM use. Among
these diseases, the cases of TKM use were highest for
soft tissue disorders (M60–M79) (3,798 cases) and other
dorsopathies (M40–M49, M53–M54) (3,183 cases).
There were also a large number of TKM use cases in ar-
throsis (M15–M19); dislocations, sprains and strains of
specified and multiple body regions (S03, S13, S23, S33,
S43, S53, S63, S73, S83, S93, T03); cervical and other
intervertebral disc disorders (M50–M51); intracranial
hemorrhages (I60–I62); and other diseases of the circu-
latory system (I85–I99). Of TKM use cases diagnosed
with one of the top twenty diseases, the highest propor-
tion of TKM use was shown in the use as the invigorant
(98.6 ± 0.51%), followed by cases with nerve, nerve root
and plexus disorders (G50–G59) (68.7 ± 1.90%), intracra-
nial hemorrhage (59.3 ± 1.31%) and other diseases of the
circulatory system (49.0 ± 1.45%); and soft tissue disor-
ders (33.1 ± 0.44%). The cost of TKM showed a similar
pattern, in that the amount and proportion of TKM
costs were highest for the use as the invigorant (99.7%);
followed by nerve, nerve root and plexus disorders
(70.1%); and other diseases of the circulatory system
(64.0%) (Table 2).
The annual number of outpatient cases and the cost of
outpatient services of chronic disease patients were
identified. The average annual cost and number of cases
of the top ten chronic diseases using TKM was high was
presented in Figures 1 and 2. Lumbar and other inter-
vertebral disc disorders patients represented the highest
annual number of outpatient cases, at 16.5 (±1.87) out-
patient visits annually among the diseases selected.
Other dorsopathies were the second most common dis-
ease (15.2 ± 1.19) visits per year) and sequelae of injuries,
poisoning and other consequences of external causes
(T90–T98); arthrosis; and soft tissue disorders followed.
The frequency of TKM use varied and patients with soft
tissue disorders most frequently used TKM, with 5.9 ±
1.00 visits and 38.6% of total visits due to soft tissue dis-
orders. Annual use of TKM was also higher for other
dorsopathies and sequelae of injuries, poisoning and
other consequences of external causes (Figure 1). In the
case of cost, the average annual cost of cervical and
other intervertebral disc disorders for outpatient service
was highest at 207.2 ± 30.67 per year. The patients with
lumbar and other intervertebral disc disorders paid the
most for TKM treatment also. They paid $67.7 ± 24.88per year for TKM treatment, while patients with other
dorsopathies paid $19.3 ± 3.18 per year and patients with
arthrosis paid $12.1 ± 4.95 per year for TKM treatment
(Figure 2).Discussion
TKM represented 0.7% of the cases and 1.0% of the ad-
mission costs for patients that required admission to a
health care institution. For patients requiring emergency
services, TKM represented only 0.4% of the cases and
0.1% of the costs. However, in terms of outpatient ser-
vices, the proportion of TKM use was relatively large.
TKM accounted for 7.8% of outpatient services and
9.9% of costs associated with outpatient services. The
following disease groups were associated with frequent
users and high costs: diseases of the musculoskeletal sys-
tem and connective tissue; diseases of the nervous sys-
tem; and symptoms, signs and abnormal clinical and
laboratory findings. In particular, outpatients with soft
tissue disorders, other dorsopathies, and arthrosis fre-
quently used TKM. Among patients with chronic dis-
eases, annual TKM use exceeded three visits in cervical
and other intervertebral disc disorders, and in soft tissue
disorders. Patients with these two types of chronic dis-
ease paid more than $30.0 annually for TKM treatment.
Because of the difference in disease classification sys-
tems, it can be difficult to determine the relative prefer-
ence and medical service use patterns of TKM and
Western medicine by disease group. In this study the
relative preference and medical service use characteris-
tics of TKM and Western medicine were determined
using a uniform disease classification system adopted by
the Korea Health Panel, showing that the relative pro-
portion of TKM use is highest in the musculoskeletal
and nervous system disease groups. The most frequent
TKM use cases are those due to musculoskeletal dis-
eases; the musculoskeletal disease group accounted for
more than half of TKM use in outpatient services in
2008. These results suggest that the use of TKM or
CAM is considered when evaluating treatment options
for certain diseases. For example, treatment of the mus-
culoskeletal system was estimated at 6.89 billion dollars
in 2008, using claims data that excludes TKM [19].
However, according to this study, TKM represents one
third of total musculoskeletal outpatient services. The
total economic burden of treating musculoskeletal sys-
tem diseases increases to 8.1 billion dollars when TKM
is taken into account. Understanding the frequency with
which certain diseases are treated is critical to create ad-
equate policy intervention, and thus TKM use should be
considered when estimating the economic burden of
certain diseases. This is relevant not only in Korea, but
in other countries where the prevalence of CAM is high.
Table 2 Number of outpatient cases and cost of outpatient medical services for the top 20 diseases treated with Traditional Korean Medicinea)

















Migraines and other headache
syndromes (G43–G44)
939 80.3% (1.16) 18.8 79.8% 229 19.6% (1.16) 4.8 20.2% 1 0.1% (0.09) 0.01 0.0% 1,169 23.6
Nerve, nerve root and plexus
disorders (G50–G59)
181 30.3% (1.88) 2.5 29.7% 410 68.7% (1.90) 5.9 70.1% 6 1.0% (0.41) 0.02 0.2% 597 8.5
Intracranial hemorrhage (I60–I62) 543 38.9% (1.30) 5.9 57.0% 828 59.3% (1.31) 4.0 38.6% 26 1.9% (0.36) 0.45 4.4% 1,397 10.3
Cerebral infarction (I63) 682 82.0% (1.30) 8.6 72.3% 147 17.7% (1.32) 3.3 27.6% 3 0.4% (0.21) 0.01 0.1% 832 11.8
Other diseases of the circulatory
system (I85–I99)
596 50.3% (1.45) 5.0 36.0% 581 49.0% (1.45) 8.9 64.0% 8 0.7% (0.24) 0.01 0.1% 1,185 13.9
Other acute upper respiratory
infections (J00–J01, J05–J06)
48,393 99.3% (0.04) 150.8 94.9% 300 0.6% (0.04) 7.3 4.6% 39 0.1% (0.01) 0.75 0.5% 48,732 158.8
Other diseases of the nose and
nasal sinuses (J30–J31, J33–J34)
4,335 94.1% (0.35) 20.1 66.2% 267 5.8% (0.34) 10.2 33.5% 5 0.1% (0.05) 0.07 0.2% 4,607 30.3
Gastritis and duodenitis (K29) 3,603 96.5% (0.30) 31.3 92.0% 118 3.2% (0.29) 2.7 7.9% 11 0.3% (0.09) 0.04 0.1% 3,732 34.0
Other diseases of the esophagus,
stomach and duodenum (K20–K23,
K28, K30–K31)
1,813 91.7% (0.62) 19.4 75.9% 158 8.0% (0.61) 5.6 22.0% 6 0.3% (0.12) 0.55 2.1% 1,977 25.6
Other diseases of the skin and
subcutaneous tissues (L10–L99)
7,207 95.9% (0.23) 68.5 82.1% 302 4.0% (0.23) 14.9 17.9% 6 0.1% (0.03) 0.03 0.0% 7,515 83.4
Rheumatoid arthritis and other
inflammatory polyarthropathies
(M05–M14)
1,317 88.2% (0.83) 9.2 84.1% 175 11.7% (0.83) 1.7 15.9% 1 0.1% (0.07) 0.01 0.1% 1,493 10.9
Arthrosis (M15–M19) 11,227 84.0% (0.32) 59.6 77.8% 2,062 15.4% (0.31) 16.8 21.9% 76 0.6% (0.07) 0.23 0.3% 13,365 76.6
Other disorders of the joints
(M00–M03, M22–M25)
830 74.2% (1.31) 7.5 70.9% 288 25.7% (1.31) 3.1 29.0% 1 0.1% (0.09) 0.00 0.0% 1,119 10.5
Cervical and other intervertebral
disc disorders (M50–M51)
4,359 77.5% (0.56) 60.7 68.1% 1,254 22.3% (0.56) 28.4 31.8% 8 0.1% (0.05) 0.15 0.2% 5,621 89.3
Other dorsopathies (M40–M49,
M53–M54)
9,514 74.2% (0.39) 64.3 66.4% 3,183 24.8% (0.38) 32.1 33.2% 127 1.0% (0.09) 0.36 0.4% 12,824 96.8
Soft tissue disorders (M60–M79) 7,664 66.7% (0.44) 52.1 61.6% 3,798 33.1% (0.44) 32.4 38.3% 23 0.2% (0.04) 0.12 0.1% 11,485 84.7
Dislocations, sprains and strains
of specified and multiple body
regions (S03, S13, S23, S33, S43,
S53, S63, S73, S83, S93, T03)
3,328 72.3% (0.66) 29.4 73.1% 1,271 27.6% (0.66) 10.4 25.8% 6 0.1% (0.05) 0.46 1.2% 4,605 40.2
Other injuries of specified,
unspecified and multiple body
regions (S00–S01, S04, S09–S11,
S14–S16, S19–S21, S24–S25,
























S94–S96,S99, T00–T01, T06–T07, T09,
T11, T13–T14)
Sequelae of injuries, poisoning and
other consequences of external
causes (T90–T98)
1,810 85.1% (0.77) 13.1 89.1% 310 14.6% (0.76) 1.4 9.7% 8 0.4% (0.13) 0.16 1.1% 2,128 14.7
the use for the invigorant 7 1.3% (0.47) 0.1 0.1% 547 98.6% (0.51) 96.7 99.7% 1 0.2% (0.18) 0.18 0.2% 555 97.0



















Figure 1 Average number of outpatient visits per year per person for top 10 chronic diseases treated with traditional Korean Medicine.
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ing that musculoskeletal problems are one of most
common reasons patients use CAM in Korea [11].
However, in previous studies, CAM was also an import-
ant treatment for obstetric/gynecological and endo-
crine disease groups, while this study found TKM useFigure 2 Average cost of outpatient visit per year per person for top 10 chin these disease groups to be relatively low. This could
result from the different types of service included in
the study. Previous research included most types of
CAM, such as TKM, diet therapies, and herbal medica-
tions [11]. This study only included TKM conducted by
an DKM.ronic diseases treated with traditional Korean Medicine.
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eases, some of whom used TKM for 10–30% of their
total medical outpatient services. For example, cervical
disc disorder patients paid an average of $64.9 annually
for TKM. Patients with soft tissue disorders such as
muscle pain also used TKM an average of 4.6 times an-
nually. A study conducted in Singapore found that more
than half of those surveyed would hypothetically prefer
CAM to Western medicine for back, joint and ankle
sprains [21]. Also another study conducted in Taiwan
which use claims data showed that main disease group
for traditional Chinese medicine were respiratory dis-
eases such as acute sinusitis and musculoskeletal dis-
eases [22]. Also musculoskeletal disease and injury were
the most common causes of acupuncture use in Taiwan
[23]. Musculoskeletal diseases are the most common
causes of CAM use which includes massage, vitamins,
acupressure, health food and Kampo in Japan also [24].
In spite of the diversity of research method between
studies, the preference for CAM for musculoskeletal dis-
eases is similar in Korea and other countries.
TKM is preferred for outpatient treatment rather than
for emergency services or services that require admis-
sion to a hospital. More specifically, musculoskeletal dis-
eases such as soft tissue disorders, other dorsopathies,
and arthrosis are the most common reasons a patient
uses TKM. These diseases include symptoms such as
back pain, neuralgia, and general muscle pain. In gen-
eral, TKM is used to treat diseases that threaten the
quality of life rather than diseases that threaten life itself.
The characteristics of TKM use in Korea support previ-
ous reports on CAM use in Korea and in other countries
[12,21,25]. In Korea, the main purpose of CAM is to
prevent disease and promote general health [12]. In
Singapore, the primary reason for CAM use was main-
tenance of health rather than treatment of illness. Even
only TKM which could be more official part of CAM is
only regarded in this study, main reasons of TKM use
are generally less life threatening diseases.
Costs associated with TKM were approximately 0.4
million dollars in Korea Health Panel. These costs of
Korea Health Panel mean that out-of-pocket costs for
TKM use would be 916.1 million dollars for total Korean
population in 2008. In addition, when the rate of health
insurance coverage at an TKM hospital (41.5%) and
clinic (67.7%) were taken into account, then the direct
medical cost that Korean paid for TKM use is estimated
at 2.6 billion dollars, which is 0.3% of the Korean gross
domestic product in 2008 [26,27].
This study used the primary diagnosis as stated by the
patient to estimate the disease-specific burden. A similar
methodology was used in previous studies and for the
official statistics of the National Health Insurance Cor-
poration [19,28]. However, the medical services used bya patient could be affected by comorbidity and not just
the primary diagnosis. Furthermore the disease definition
by patients could raise the question on the accuracy of
diagnosis. And because our study is the cross sectional
study, the trend of TKM use could not be estimated. In
addition, the use of a medical institution such as a health
care center that offers both TKM and Western medicine
was regarded as other medical service use, which could
have confound the estimates of TKM use. Also, the Korea
Health Panel does not include information about pay-
ments by the insurer, and therefore total expenditures as-
sociated with TKM could not be measured accurately. As
well, because we focus on the disease specific differences
of TKM use, the characteristics of TKM users, the treat-
ment modalities of TKM and the difference between
TKM users and non-users are not analyzed. And the effi-
cacy of TKM or the treatment modality among TKM are
not analyzed this study. Therefore, further researches on
these subjects are needed.
Conclusion
Though TKM represents a substantial part of Korean
health care, information about disease-specific use of
TKM and Western medicine is not well known due to
differences in disease classification systems between the
two types of medicine. This study used data from the
Korea Health Panel and determined that TKM repre-
sented only a small proportion of emergency services
and services requiring admission to a hospital, though it
plays a substantial role in outpatient medical care. The
total number of cases and patient expenditures indicate
that TKM is used as an important modality for treating
musculoskeletal and nervous system diseases, including
soft tissue disorders and arthrosis. The characteristics of
TKM use in Korea are similar to other countries. TKM
use should be considered when estimating the economic
burden of certain diseases, particularly in countries with
parallel health care systems such as Korea. To the best
of the author’s knowledge, this is the first study that de-
termined the actual preference of TKM use in patients
with chronic diseases in Korea in the adults.
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